Biotechnology industry in Boston

Greater Boston, primarily Boston and Cambridge, is home to almost 1,000 biotechnology companies, ranging from small start-ups to billion-dollar pharmaceutical companies. The many universities in the area give the region a large network of scientists.[1]

Kendall Square area, viewed from across the Charles River
The Harvard Medical School quadrangle and adjacent Longwood Medical and Academic Area in Boston, Massachusetts

The Kendall Square area of Boston holds a large concentration of the life science industry, numbering over 120 companies within a mile,[2][3] and has been described as the "center of the nation’s biotechnology industry".[4] The Longwood area is about two miles from Kendall Square, and is also home to many biomedical research companies.[5]

History

The biotechnology industry in Boston dates back to the 1970s, when genetic engineering was developing. Biogen was the first company in Boston focused on biotechnology.[6][7]

In 2008, the governor of Massachusetts announced the Massachusetts Life Sciences Act, promising $1 billion to further the development of the biotech industry.[8][9] Massachusetts is among the top states for biotech jobs.[10]

In 2016, venture investment in Massachusetts biopharma companies was $2.9 billion, and more than half of the biotech companies in the state receiving venture capital were located in Cambridge. When Cambridge and Boston were considered together, they received more than 80% of the funding in the state.[11] Seven teaching hospitals are located in Boston, contributing to the research efforts. Five of the top six NIH-funded independent hospitals in the United States are located in Boston.[12]

Local industry
The Broad Institute is located in the life sciences hub of Kendall Square

Academic institutes

Biotechnology companies

Pharmaceutical companies

See also

References
  1. Ramsey, Lydia (May 13, 2017). "Insiders reveal how Boston moved to the forefront of the global fight against deadly diseases". Business Insider. Retrieved 20 November 2019.
  2. Garde, Damian (5 May 2016). "Get to know Kendall Square, biotech's booming epicenter". STAT.
  3. Ledford, Heidi (11 June 2015). "Start-ups fight for a place in Boston's biotech hub". Nature. 522 (7555): 138–139. Bibcode:2015Natur.522..138L. doi:10.1038/522138a. PMID 26062489.
  4. Logan, Tim. "Developers are scrambling for the next Kendall Square. Where will it be?". The Boston Globe. Retrieved 21 February 2019.
  5. "Spotlight on Boston/Cambridge". Nature. 13 June 2012. doi:10.1038/nj0376. Retrieved 20 November 2019.
  6. "Clusterluck". The Economist. January 16, 2016.
  7. Khalid, Asma (June 19, 2017). "How Boston Became 'The Best Place In The World' To Launch A Biotech Company". WBUR (BostonomiX).
  8. "Life Sciences Initiative". www.mass.gov.
  9. "Gov. Patrick and the Mass. Life Sciences Center Announce Over $100 Million in Capital Grant Funding for Projects in Western Mass". Office of News & Media Relations | UMass Amherst.
  10. Saltzman, Jonathan (January 6, 2019). "For biotech, 2019's not a sky's-the-limit year - The Boston Globe". The Boston Globe. Retrieved 12 April 2019.
  11. "Mass Bio Industry Snapshot 2017" (PDF). Massachusetts Biotechnology Council. 2017.
  12. "Mass Bio Industry Snapshot 2016" (PDF). Massachusetts Biotechnology Council. 2016.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.